Betahistine dihydrochloride (brand names Veserc Serc Hiserk Betaserc) is an antivertigo drug. It was first registered in Europe in 1970 for the treatment of Ménière’s disease. It is commonly prescribed to patients with balance disorders or to alleviate vertigo symptoms associated with Ménière’s disease.
This page contains content from the copyrighted Wikipedia article "Betahistine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
